Fowl Cholera in Poultry: Pasteurella Multocida Pathogenesis, Clinical Signs, and Outbreak Management

Fowl cholera is a highly contagious bacterial disease of domestic poultry and many wild bird species. It is caused by the Gram-negative coccobacillus Pasteurella multocida and presents in acute, subacute, or chronic forms. In layer and breeder flocks, acute outbreaks can result in sudden mortality exceeding 50%, while chronic infection manifests as localized inflammation of wattles, sinuses, and joints. This article provides a detailed examination of the pathogenesis, clinical presentation, diagnostic modalities, antimicrobial therapy, and integrated outbreak management strategies for fowl cholera in poultry.

Etiology and Serotype Classification

Pasteurella multocida is a nonmotile, facultatively anaerobic, bipolar-staining Gram-negative rod. The capsule is a key virulence determinant; capsular serogroups A, B, D, E, and F are recognized based on antigenic specificity. In poultry, capsular type A and, less frequently, type D are associated with fowl cholera. Somatic lipopolysaccharide antigens define 16 serovars (1 through 16) by the Heddleston scheme. The most common somatic serovars isolated from North American poultry outbreaks are 1, 3, and 4. Mixed infections with multiple serovars occur in endemic flocks.

Molecular typing methods such as pulsed-field gel electrophoresis and multilocus sequence typing provide higher discriminatory power than serotyping alone. These techniques are essential for tracking outbreak strains and distinguishing vaccine strains from field isolates.

Pathogenesis

Fowl cholera pathogenesis involves colonization of the upper respiratory tract followed by invasion into the bloodstream. The primary portal of entry is the nasal mucosa and oropharynx. Virulence factors that facilitate this process include:

• Capsular polysaccharide (hyaluronic acid in serogroup A): antiphagocytic, inhibits complement-mediated opsonization.
• Lipopolysaccharide (LPS): endotoxin responsible for fever, coagulopathy, and shock.
• Adhesins (e.g., filamentous hemagglutinin): mediate attachment to respiratory epithelium.
• Siderophores: acquire iron from host transferrin and lactoferrin.
• Outer membrane proteins (OMPs): involved in nutrient acquisition and immune evasion.
• Toxins: some strains produce a dermonecrotic toxin (PMT), though its role in avian disease is less defined than in porcine atrophic rhinitis.

Once the bacteria breach the mucosal barrier, they enter local lymphatics and the bloodstream, resulting in a rapidly lethal septicemia. Endotoxin release triggers disseminated intravascular coagulation, vascular leakage, and multiorgan failure. In chronic cases, bacteria localize in wattles, joint spaces, and sinuses, leading to fibrinopurulent inflammation.

Clinical Signs

Clinical presentation depends on the virulence of the strain, host immune status, and route of exposure.

Acute Form

• Peracute mortality: birds found dead without premonitory signs.
• Acute sepsis: depression, anorexia, ruffled feathers, cyanosis of comb and wattles, mucoid diarrhea, increased respiratory rate, and fever (up to 44 degrees Celsius).
• Mortality peaks within 48 to 72 hours; flock mortality can reach 50% in unvaccinated layers.

Subacute Form

• Less severe depression and anorexia.
• Swollen, edematous wattles (often unilateral) due to localized infection.
• Mucopurulent discharge from nares and conjunctivitis.
• Lameness from septic arthritis or synovitis.

Chronic Form

• Persistent swelling of wattles and sinuses (caseous exudate).
• Torticolis and other neurologic signs secondary to meningitis or middle ear infection.
• Decreased egg production and increased culling.

In breeder flocks, a drop in egg production and fertility may precede overt clinical signs.

Gross Pathology and Histopathology

Acute Lesions

• Petechial and ecchymotic hemorrhages on epicardium, serosal surfaces, and abdominal fat.
• Hepatomegaly with pale, mottled appearance and focal necrosis.
• Splenomegaly (often two to three times normal size).
• Congested lungs and pulmonary edema.
• Fibrinous pericarditis and peritonitis in some cases.

Chronic Lesions

• Caseous necrotic cores in wattles and sinuses.
• Fibrinous arthritis and tenosynovitis.
• Otitis media with purulent exudate in the tympanic cavity.
• Pneumonia and airsacculitis.

Histologically, acute cases show fibrinoid necrosis of blood vessels, thrombus formation, and massive infiltration of heterophils and macrophages in affected organs. Chronic lesions are characterized by fibrocaseous exudate surrounded by epithelioid macrophages and multinucleated giant cells.

Differential Diagnosis

The following table lists conditions that can mimic fowl cholera and key differentiating features.

Diagnostic Methods

Rapid and accurate diagnosis is critical for implementing control measures. A combination of clinical history, necropsy, and laboratory testing is recommended.

Bacterial Culture

• Sample types: swabs from liver, spleen, bone marrow, heart blood, or wattles (acute deaths); swabs from sinus exudate or joint fluid (chronic cases).
• Media: tryptic soy agar or blood agar supplemented with 5% sheep blood; P. multocida grows as small, dewdrop-like, nonhemolytic colonies. Selective media containing antibiotics (e.g., MacConkey agar with 1% glucose) may enhance isolation.
• Incubation: 35 to 37 degrees Celsius in 5% CO2 for 24 to 48 hours.
• Identification: Gram-negative bipolar staining; oxidase positive; catalase positive; indole positive; nitrate reduction positive. Commercial biochemical strips or MALDI-TOF mass spectrometry provide definitive identification.

Molecular Detection

• Conventional PCR: targets the kmt1 gene (species-specific) and capsular serogroup genes (hyaD-hyaC for type A, dcbF for type D). Multiplex PCR panels can simultaneously detect somatic serovars.
• Real-time PCR: more sensitive for detection of carrier birds or environmental samples.
• Sequencing: whole genome sequencing enables high-resolution strain typing and antimicrobial resistance gene profiling.

Serology

• ELISA: detects antibodies against P. multocida and is used for vaccine efficacy monitoring. Commercial ELISA kits are available but cross-reactivity with other Pasteurella species occurs.
• Agar gel immunodiffusion: used for serotyping (Heddleston method).

Antimicrobial Susceptibility Testing

• Disk diffusion or broth microdilution should be performed to guide therapy, as resistance to tetracyclines and sulfonamides is increasingly reported. Minimum inhibitory concentration (MIC) breakpoints established by the Clinical and Laboratory Standards Institute (CLSI) for Pasteurella spp. should be used.

Treatment

Antimicrobial intervention must be instituted promptly during an outbreak. Because fowl cholera is often peracute, medicated feed or water is the primary route of administration.

Recommended Antimicrobial Classes

• Tetracyclines: chlortetracycline or oxytetracycline at 200 to 400 g per ton of feed for 5 to 7 days; or in drinking water at 10 to 20 mg per kg body weight.
• Penicillins: amoxicillin or ampicillin at 10 to 20 mg per kg body weight intramuscularly or orally; less practical for large flocks.
• Sulfonamides: sulfadimethoxine or sulfaquinoxaline at 0.05% to 0.1% in drinking water for 3 to 5 days.
• Fluoroquinolones: enrofloxacin at 10 mg per kg body weight intramuscularly or orally (extra-label in some jurisdictions).
• Phenicols: florfenicol (injectable or in feed) effective against many resistant strains.

Antimicrobial sensitivity testing is strongly advised, especially in flocks with previous exposure or recurrent outbreaks.

Supportive Care

• Reduce stress: minimize handling, maintain optimal ventilation, ensure adequate nutrition.
• Remove and incinerate dead birds to reduce environmental contamination.
• Correct water sanitation and prevent fecal-oral transmission.

Prevention and Control

Vaccination

Vaccination is the cornerstone of fowl cholera prevention in layer and breeder flocks. Commercially available vaccines include inactivated (bacterins) and live attenuated products.

• Inactivated vaccines: bacterins contain multiple serovars; typically administered intramuscularly or subcutaneously in two doses (2 to 4 weeks apart). Immunity lasts 3 to 6 months. Adverse effects include local swelling and transient egg drop.
• Live attenuated vaccines: derived from avirulent strains (e.g., PM-1 or M-9); administered in drinking water or via spray. They provide better cell-mediated immunity but carry a risk of reversion to virulence.
• Autogenous vaccines: prepared from the flock-specific field isolate; used when commercial vaccines fail.
• Combination vaccines: often combined with Newcastle disease or infectious bronchitis virus antigens.

Booster vaccinations every 3 to 6 months are recommended in endemic areas.

Biosecurity

• Implement all-in/ all-out management.
• Prevent contact with wild birds (especially waterfowl, which are reservoirs). See Avian Cholera in Waterfowl: Pasteurella multocida Serotypes, Outbreak Dynamics, and Vaccination Approaches in Wild and Domestic Birds.
• Rodent control: rodents can mechanically transmit P. multocida.
• Disinfect housing between flocks using phenol-based or quaternary ammonium disinfectants effective against Gram-negative bacteria.
• Quarantine new birds for 2 to 3 weeks and test for carrier status via PCR.

Carrier Detection

Asymptomatic carriers (often in the upper respiratory tract) perpetuate outbreaks. Tonsil or choanal swab culture combined with PCR can identify carriers. Culling seropositive birds is sometimes practiced in high-value breeder flocks.

Outbreak Management

A structured outbreak response is necessary to minimize economic losses. The following decision tree summarizes key steps.

flowchart TD
    A["Suspected fowl cholera outbreak"], > B["Observe clinical signs<br/>(sudden death, cyanosis, swollen wattles)"]
    B, > C["Necropsy and sample collection<br/>(liver, spleen, heart blood, wattles)"]
    C, > D["Laboratory confirmation<br/>(culture, PCR, serotyping)"]
    D, > E{"Confirmed?}
    E, Yes, > F["Isolate serotype and determine MIC"]
    E, No, > G["Consider differential diagnoses<br/>(HPAI, ND, erysipelas, etc.)"]
    F, > H["Implement quarantine and movement restrictions"]
    H, > I["Administer antimicrobial<br/>(in water or feed based on sensitivity)"]
    I, > J["Remove and dispose of carcasses<br/>(incineration or composting)"]
    J, > K["Enhance biosecurity<br/>(disinfect housing, control wild birds and rodents)"]
    K, > L["Vaccinate remaining birds<br/>(booster or autogenous vaccine)"]
    L, > M["Monitor mortality and clinical signs for 14 days"]
    M, > N{"Mortality declines?}
    N, Yes, > O["Resume normal operations after cleaning and disinfection"]
    N, No, > P["Re-evaluate antimicrobial choice and consider carrier status"]
    P, > I

Key additional measures:

• Notify the relevant veterinary authority; fowl cholera is a World Organisation for Animal Health (WOAH) listed disease.
• Restrict movement of poultry, eggs, and equipment from affected farms.
• Conduct trace-back investigations for potential sources (e.g., live bird markets, contaminated feed, nearby waterfowl habitats).
• In layer flocks, depopulation may be considered if mortality exceeds 20% despite treatment.

Antimicrobial Resistance Considerations

Resistance to commonly used antibiotics such as tetracyclines and sulfonamides has been documented in P. multocida isolates from poultry. Resistance determinants (tet genes, sul genes) are often carried on mobile genetic elements and plasmids. Prudent use of antimicrobials, guided by culture and sensitivity, is essential. Rotating drug classes within a flock and avoiding prophylactic use can help slow resistance development. Molecular surveillance of resistance genes via PCR or whole genome sequencing is recommended for integrated programs. For a broader context on AMR in livestock settings, refer to Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus: Genomic Epidemiology and One Health Implications.

Conclusion

Fowl cholera remains a significant threat to poultry production worldwide. Successful management depends on rapid diagnosis, targeted antimicrobial therapy, robust biosecurity, and effective vaccination. The emergence of antimicrobial resistance underscores the need for integrated control strategies that reduce reliance on antibiotics. Molecular tools have enhanced our ability to type strains and track outbreaks, enabling more precise interventions. Future research should focus on improved cross-protective vaccines and non-antibiotic alternatives such as bacteriophages and immunomodulators.

References

1. Glisson JR, Hofacre CL, Christensen JP. Pasteurellosis. In: Swayne DE, editor. Diseases of Poultry. 14th ed. Hoboken (NJ): Wiley-Blackwell; 2020. p. 831-860.

2. Christensen JP, Bisgaard M. Fowl cholera in Denmark: a retrospective analysis of Pasteurella multocida isolates from poultry. Avian Pathol. 2000;29(5):449-456.

3. Wilkie IW, Harper M, Boyce JD, Adler B. Pasteurella multocida: diseases and pathogenesis. Curr Top Microbiol Immunol. 2012;361:1-22.

4. Snipes KP, Carpenter TE, Corn JL, et al. Pasteurella multocida in wild mammals and birds in California: prevalence and virulence for turkeys. Avian Dis. 1988;32(4):698-706.

5. Shivaprasad HL. Pathology of birds: an overview. In: Terio KA, McAloose D, St. Leger J, editors. Pathology of Wildlife and Zoo Animals. San Diego: Academic Press; 2018. p. 773-810.

6. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals. 5th ed. CLSI supplement VET01S. Wayne (PA): CLSI; 2020.

7. World Organisation for Animal Health. Fowl Cholera. In: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Paris: OIE; 2022. Chapter 3.3.5.